Sending out an S...O...S to Quest!

It would not make a difference? AmeriPath (like many other companies) has been taking a portion of our market share all year with new reps. Would assume they (and other companies) will do the same as they expand. I know docs tell me what their message is: strong managed care contracts, they don't over utlilize testing to make up for poor reimbursement (unethical), and the fact that they actually perform work within the same company (molecular), unlike us, who sends to Quest anyway.

Don't be so bitter, just look at facts for what they are.